Back to Authors

Taunton, Michael J

0000-0002-7636-0489

Mayo Clinic

Department of Orthopedics, Mayo Clinic, Rochester, Minnesota.

Citations 46

The monitoring of activity at home after total hip arthroplasty
Toogood, Paul , Spear, Joshua A. , Cook, S. M., Taunton, Michael J. , Abdel, Matthew P. , Cook, David J. , Taunton, Michael J

The Bone & Joint Journal | November 1, 2016 | Volume: 98-B | Issue: 11 | Pages: 1450-1454

10.1302/0301-620x.98b11.bjj-2016-0194.r1 Get It

Aims Total hip arthroplasty (THA) has well known subjective benefits, but little is known objectively about the recovery of mobility in the early post-operative period. Patients and Methods A total of 33 patients aged > 60 years who underwent elective primary THA had their activity monitored for 30 days post-operatively using an at-home (Fitbit) ankle accelerometer. Their mean age was 70.7 years (61 to 86); 15 (45.5%) were female. The rate of compliance and the mean level of activity were determined. Comparisons between subgroups based on age, body mass index (BMI), surgical approach, and the destination of the patients when discharged were also performed. Results The mean compliance over the 30 days was 26.7 days (16 to 30; 89%) of use. The mean number of steps increased from 235 (5 to 1152) to 2563 (87 to 7280) (p < 0.001) between the first and the 30th post-operative day. Age < 70 years and an anterior surgical approach were significantly associated with higher levels of activity (1600 to 2400 (p = 0.016 to 0.031) and 1000 to 1800 (p = 0.017 to 0.037) more steps per day, respectively) between the second and the fourth week post-operatively. There was also a trend towards higher levels of activity in those who were discharged to their home rather than to a nursing facility (a mean of 1500 more steps per day, p = 0.02). BMI greater or less than 30 kg/m 2 was not predictive of activity (p = 0.45 to 0.98). Conclusion At-home remote mobility monitoring using existing commercially available technology is feasible in patients who have undergone THA. It showed a clear trend towards increased activity with the passage of time. Additionally, the remote device was able to detect differences in levels of activity clearly between patients in relation to variables of interest including age, BMI, surgical approach, and the destination of the patient at the time of discharge from hospital. Such monitoring may allow for the early identification and targeted intervention in patients who recover slowly. Cite this article: Bone Joint J 2016;98-B:1450–4.
Prior bariatric surgery may decrease the rate of re-operation and revision following total hip arthroplasty
Martin, J. Ryan , Abdel, M., Lewallen, David G. , Taunton, Michael J. , Watts, Chad D. , Houdek, Matthew T. , Taunton, Michael J

The Bone & Joint Journal | September 1, 2016 | Volume: 98-B | Issue: 9 | Pages: 1180-1184

10.1302/0301-620x.98b9.37943 Get It

Aims We compared the outcome of total hip arthroplasty (THA) in obese patients who previously underwent bariatric surgery and those who did not, in a matched cohort study. Patients and Methods There were 47 THAs in the bariatric group (42 patients), and 94 THAs in the comparison group (92 patients). The mean age of the patients was 57 years in both groups (24 to 79) and 57% of the patients in both groups were women. The mean time between bariatric surgery and THA was five years (four months to 12 years) in the bariatric group. The mean follow-up after THA was three years (2 to 9). Results The mean BMI improved from 49.7 kg/m2 (35 to 75) prior to bariatric surgery to 35.3 kg/m2 (21 to 49) at the time of THA (p < 0.001). Patients in the comparison group had an increased risk of re-operation (Hazard Ratio (HR) 3.2; 95% confidence intervals (CI) 1.3 to 9.5, p = 0.01) and revision (HR 5.4; 95% CI 1.5 to 34.5, p = 0.01) when compared with the bariatric group. Conclusion Patients had a dramatic improvement in BMI after bariatric surgery and those with prior bariatric surgery had a lower risk of re-operation and revision in the short- and mid-term after a subsequent THA. Larger prospective studies are required before it can be concluded that this extra surgery should be advised in these patients. Cite this article: Bone Joint J 2016;98-B:1180–4.
Functional and oncologic outcome of cemented endoprosthesis for malignant proximal femoral tumors
Watts, Chad D. , Rose, Peter S. , Taunton, Michael J. , Sim, Franklin H. , Wyles, Cody C. , Houdek, Matthew T. , Taunton, Michael J , Pagnano, Mark W

Journal of Surgical Oncology | June 29, 2016 | Volume: 114 | Issue: 4 | Pages: 501-506

10.1002/jso.24339 Get It

Bariatric surgery does not improve outcomes in patients undergoing primary total knee arthroplasty
Martin, J. Ryan , Watts, Chad D. , Taunton, Michael J. , Taunton, Michael J , Pagnano, Mark W

The Bone & Joint Journal | November 3, 2015 | Volume: 97-B | Issue: 11 | Pages: 1501-1505

10.1302/0301-620x.97b11.36477 Get It

Bariatric surgery has been advocated as a means of reducing body mass index (BMI) and the risks associated with total knee arthroplasty (TKA). However, this has not been proved clinically. In order to determine the impact of bariatric surgery on the outcome of TKA, we identified a cohort of 91 TKAs that were performed in patients who had undergone bariatric surgery (bariatric cohort). These were matched with two separate cohorts of patients who had not undergone bariatric surgery. One was matched 1:1 with those with a higher pre-bariatric BMI (high BMI group), and the other was matched 1:2 based on those with a lower pre-TKA BMI (low BMI group). In the bariatric group, the mean BMI before bariatric surgery was 51.1 kg/m2 (37 to 72), which improved to 37.3 kg/m2 (24 to 59) at the time of TKA. Patients in the bariatric group had a higher risk of, and worse survival free of, re-operation (hazard ratio (HR) 2.6; 95% confidence interval (CI) 1.2 to 6.2; p = 0.02) compared with the high BMI group. Furthermore, the bariatric group had a higher risk of, and worse survival free of re-operation (HR 2.4; 95% CI 1.2 to 3.3; p = 0.2) and revision (HR 2.2; 95% CI 1.1 to 6.5; p = 0.04) compared with the low BMI group. While bariatric surgery reduced the BMI in our patients, more analysis is needed before recommending bariatric surgery before TKA in obese patients. Cite this article: Bone Joint J 2015;97-B:1501–5.
Late Complications and Long-Term Outcomes following Aseptic Revision of a Hip Arthroplasty Performed for Oncological Resection
Wagner, Eric R. , Wilke, Benjamin K. , Taunton, Michael J. , Sim, Franklin H. , Wyles, Cody C. , Houdek, Matthew T. , Wilke, B K , Wagner, Eric R , Taunton, Michael J

HIP International | October 2, 2015 | Volume: 25 | Issue: 5 | Pages: 428-434

10.5301/hipint.5000280 Get It

Purpose In order to achieve an oncological margin during limb salvage surgery for tumours around the hip, part or the entire hip joint is frequently sacrificed. Hip arthroplasty restores a functional extremity and achieves limb salvage. Currently there is a paucity of data concerning the late complications, long-term survival, and the risks of re-revision following aseptic revision of a total hip arthroplasty (THA) performed following an oncological resection. Methods We identified 78 patients who underwent aseptic revision of a THA which was performed for an oncological process involving the hip from 1972 to 2006. All patients had a minimum 5 years of follow-up with a mean of 13 years. Outcomes were compared to 1,378 patients undergoing aseptic revision of a THA that was performed for a diagnosis of osteoarthritis. Results The mean 5-, 10-, 15-, and 20-year re-revision-free survival for an oncologic process of the hip was 100%, 85%, 69%, and 57%. Within this cohort, younger patients were at an increased risk of revision surgery. There was no difference in survivorship of the revision implant at any of the aforementioned time points between the oncologic and osteoarthritis cohorts. Patients with an oncologic diagnosis had a higher rate of dislocations, component wear, and loosening compared to the osteoarthritis group. Conclusion Late complications following revision surgery of THA performed for an oncologic resection are common. The results of this study provide information for counselling patients on implant survivorship and complications following aseptic revision THA after index surgery for an oncologic indication.
Seronegative infections in hip and knee arthroplasty
McArthur, Benjamin A., Taunton, Michael J. , Osmon, Douglas R. , Hanssen, Arlen D. , Abdel, Matthew P. , Taunton, Michael J

The Bone & Joint Journal | June 30, 2015 | Volume: 97-B | Issue: 7 | Pages: 939-944

10.1302/0301-620x.97b7.35500 Get It

The aim of our study was to describe the characteristics, treatment, and outcomes of patients with periprosthetic joint infection (PJI) and normal inflammatory markers after total knee arthroplasty (TKA) and total hip arthroplasty (THA).In total 538 TKAs and 414 THAs underwent surgical treatment for PJI and met the inclusion criteria. Pre-operative erythrocyte sedimentation rate (ESR) and C-reactive protein level (CRP) were reviewed to identify the seronegative cohort. An age- and gender-matched cohort was identified from the remaining patients for comparison. Overall, 4% of confirmed infections were seronegative (21 TKA and 17 THA). Of those who underwent pre-operative aspiration, cultures were positive in 76% of TKAs (n = 13) and 64% of THAs (n = 7). Cell count and differential were suggestive of infection in 85% of TKA (n = 11) and all THA aspirates (n = 5). The most common organism was coagulase-negative Staphylococcus. Seronegative infections were associated with a lower aspirate cell count and a lower incidence of Staphylococcus aureus infection. Two-stage revision was performed in 35 cases (95%). At a mean of five years (14 to 162 months) following revision, re-operation for infection occurred in two TKAs, and one THA. From our study we estimate around 4% of patients with PJI may present with normal ESR and CRP. When performed, pre-operative aspirate is useful in delivering a definitive diagnosis. When treated, similar outcomes can be obtained compared with patients with positive serology.Cite this article: Bone Joint J 2015;97-B:939–44.